drugset / Trial / NCT04784897
A Study to Evaluate the Efficacy and Safety of Brilacidin in Hospitalized Participants With COVID-19
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The study assessed the efficacy and safety of Brilacidin for the treatment of COVID-19 in hospitalized participants
Timeline
- Start
- 2021-02-22
- Primary completion
- 2021-07-01
- Completion
- 2021-07-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Brilacidin | Other / unclassified | — | Intravenous |